Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1973 Dec;35(12):1285–1292. doi: 10.1136/hrt.35.12.1285

Comparative study of alprenolol and methyldopa in previously untreated essential hypertension.

J A Vedin, C E Wilhelmsson, L Werkö
PMCID: PMC458796  PMID: 4586374

Full text

PDF
1285

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablad B., Brogård M., Ek L. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist. Acta Pharmacol Toxicol (Copenh) 1967;25:9–40. [PubMed] [Google Scholar]
  2. Bengtsson C. Comparison between alprenolol and chlorthalidone as antihypertensive agents. Acta Med Scand. 1972 May;191(5):433–439. [PubMed] [Google Scholar]
  3. Carstairs K. C., Breckenridge A., Dollery C. T., Worlledge S. M. Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet. 1966 Jul 16;2(7455):133–135. doi: 10.1016/s0140-6736(66)92422-6. [DOI] [PubMed] [Google Scholar]
  4. DOLLERY C. T. ALPHA-METHYLDOPA IN THE TREATMENT OF HYPERTENSION. Med Clin North Am. 1964 Mar;48:335–345. doi: 10.1016/s0025-7125(16)33467-8. [DOI] [PubMed] [Google Scholar]
  5. GILLESPIE L., Jr, OATES J. A., CROUT J. R., SJOERDSMA A. Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension. Circulation. 1962 Feb;25:281–291. doi: 10.1161/01.cir.25.2.281. [DOI] [PubMed] [Google Scholar]
  6. Hamilton M. Some aspects of the long-term treatment of severe hypertension with methyldopa. Postgrad Med J. 1968 Jan;44(507):66–69. doi: 10.1136/pgmj.44.507.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hansson L., Malmcrona R., Olander R., Rosenhall L., Westerlund A., Aberg H., Hood B. Propranolol in hypertension. Report on 158 patients treated up to one year. Klin Wochenschr. 1972 Apr 1;50(7):364–369. doi: 10.1007/BF01486832. [DOI] [PubMed] [Google Scholar]
  8. Hilden T., Nilsson R. Metyl-dopa i behandlingen af hypertension. Tidsskr Nor Laegeforen. 1968 Jul 15;88(14):1416–1420. [PubMed] [Google Scholar]
  9. Horwitz D., Pettinger W. A., Orvis H., Thomas R. E., Sjoerdsma A. Effects of methyldopa in fifty hypertensive patients. Clin Pharmacol Ther. 1967 Mar-Apr;8(2):224–234. doi: 10.1002/cpt196782224. [DOI] [PubMed] [Google Scholar]
  10. Hunter E., Raik E., Gordon S., Taylor K. B. Incidence of positive Coombs' test, LE cells and antinuclear factor in patients on alpha-methyldopa ("Aldomet") therapy. Med J Aust. 1971 Oct 16;2(16):810–812. doi: 10.5694/j.1326-5377.1971.tb92557.x. [DOI] [PubMed] [Google Scholar]
  11. Mohammed S., Fasola A. F., Privitera P. J., Lipicky R. J., Martz B. L., Gaffney T. E. Effect of methyldopa on plasma renin activity in man. Circ Res. 1969 Nov;25(5):543–548. doi: 10.1161/01.res.25.5.543. [DOI] [PubMed] [Google Scholar]
  12. OATES J. A., GILLESPIE L., UDENFRIEND S., SJOERDSMA A. Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine. Science. 1960 Jun 24;131(3417):1890–1891. doi: 10.1126/science.131.3417.1890. [DOI] [PubMed] [Google Scholar]
  13. ONESTI G., BREST A. N., NOVACK P., MOYER J. H. Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension. Am J Cardiol. 1962 Jun;9:863–867. doi: 10.1016/0002-9149(62)90211-4. [DOI] [PubMed] [Google Scholar]
  14. Paterson J. W., Dollery C. T. Effect of propranolol in mild hypertension. Lancet. 1966 Nov 26;2(7474):1148–1150. doi: 10.1016/s0140-6736(66)90471-5. [DOI] [PubMed] [Google Scholar]
  15. Prichard B. N., Gillam P. M. Propranolol in hypertension. Am J Cardiol. 1966 Sep;18(3):387–393. doi: 10.1016/0002-9149(66)90059-2. [DOI] [PubMed] [Google Scholar]
  16. Prichard B. N., Gillam P. M. Treatment of hypertension with propranolol. Br Med J. 1969 Jan 4;1(5635):7–16. doi: 10.1136/bmj.1.5635.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SHEPS S. G., SCHIRGER A., OSMUNDSON P. J., FAIRBAIRN J. F., 2nd Methydopa for treatment of hypertension. JAMA. 1963 May 25;184:616–621. doi: 10.1001/jama.1963.03700210050008. [DOI] [PubMed] [Google Scholar]
  18. Sannerstedt R., Stenberg J., Johnsson G., Werkö L. Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man. Am J Cardiol. 1971 Sep;28(3):316–320. doi: 10.1016/0002-9149(71)90120-2. [DOI] [PubMed] [Google Scholar]
  19. Sannerstedt R., Stenberg J., Vedin A., Wilhelmsson C., Werkö L. Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment. Am J Cardiol. 1972 May;29(5):718–723. doi: 10.1016/0002-9149(72)90176-2. [DOI] [PubMed] [Google Scholar]
  20. Tarazi R. C., Dustan H. P. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol. 1972 May;29(5):633–640. doi: 10.1016/0002-9149(72)90164-6. [DOI] [PubMed] [Google Scholar]
  21. Worlledge S. M., Carstairs K. C., Dacie J. V. Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy. Lancet. 1966 Jul 16;2(7455):135–139. doi: 10.1016/s0140-6736(66)92423-8. [DOI] [PubMed] [Google Scholar]
  22. Zacharias F. J., Cowen K. J. Controlled trial of propranolol in hypertension. Br Med J. 1970 Feb 21;1(5694):471–474. doi: 10.1136/bmj.1.5694.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Zacharias F. J., Cowen K. J., Prestt J., Vickers J., Wall B. G. Propranolol in hypertension: a study of long-term therapy, 1964-1970. Am Heart J. 1972 Jun;83(6):755–761. doi: 10.1016/0002-8703(72)90206-2. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES